Elisaveta Snezhkova

Dr. Elisaveta Snezhkova

RE Kavetsky Institute of experimental Pathology, Oncology and Radiobiology, National Academy of Sciences of Ukraine
orcid

Research Focus & Metrics

Academic Career Length

45Years (1982-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2016 in Carbon
Verified
Journal Article
Open access
CHC.A. Howell
C.A. Howell
SSS.R. Sandeman
S.R. Sandeman
YZY. Zheng
Y. Zheng
SMSergey Mikhalovsky
Sergey Mikhalovsky
VNV.G. Nikolaev
V.G. Nikolaev
ESElisaveta Snezhkova
Elisaveta Snezhkova
Activated carbon (AC) can be used for blood purification (hemoperfusion) to treat a range of conditions by direct perfusion of blood through an adsorbent column. The clinical effects of hemoperfusion relate to the AC adsorptive capacity, and any inflammatory response generated by direct blood contact

1 June 2008 in Carbon
Verified
Journal Article
Closed access
SLShouping Li
Shouping Li
WWWei Wu
Wei Wu
SCStéphane Campidelli
Stéphane Campidelli
VSVeronika Sarnatskaïa
Veronika Sarnatskaïa
MPMaurizio Prato
Maurizio Prato
ESElisaveta Snezhkova
Elisaveta Snezhkova

30 October 2010 in Adsorption
Verified
Journal Article
Closed access
PDF file
VGV. M. Gun’ko
V. M. Gun’ko
VTV. V. Turov
V. V. Turov
OKO. P. Kozynchenko
O. P. Kozynchenko
VNV. G. Nikolaev
V. G. Nikolaev
STS. R. Tennison
S. R. Tennison
SMSergey Mikhalovsky
Sergey Mikhalovsky

2 September 2008 in Chemical Communications
Verified
Journal Article
Closed access
PDF file
TPTae-Joon Park
Tae-Joon Park
SLSang-Hyun Lee
Sang-Hyun Lee
TSTrevor J. Simmons
Trevor J. Simmons
JMJeffrey G. Martin
Jeffrey G. Martin
Shaker A MousaShaker A Mousa
Shaker A Mousa
RLRobert Linhardt
Robert Linhardt
We report novel heparin–cellulose–charcoal composites prepared using room temperature ionic liquids (RTILs) to enhance the biocompatibility and blood compatibility of activated charcoal beads while decreasing the size of their active pores.

2 September 2019 in Medicina
Verified
Journal Article
Open access
PDF file
OSOksana Shevchuk
Oksana Shevchuk
ESElisaveta Snezhkova
Elisaveta Snezhkova
VSVeronika Sarnatskaya
Veronika Sarnatskaya
VMVictor Mikhailenko
Victor Mikhailenko
AGAlexei Glavin
Alexei Glavin
VNVolodymyr Nikolaev
Volodymyr Nikolaev
Background and Objectives: Side effects of anti-cancer drugs are usually accompanied by oxidative stress, including myelotoxicity. We evaluated the potential of oral highly activated micro-/macroporous carbon adsorbents (bulk density of 0.16 g/cm3, surface area calculation by Brunauer–Emmett–Teller model (SBET) > 2200 m2/g, derived from proprietary phenolic resin beads) to alleviate oxidative stress and myelotoxicity in rats. Materials and Methods: A single injection of cytostatic melphalan (L-PAM) at a dose of 4 mg/kg was used for modelling. Two forms of activated carbon were used: AC1—primary beads with the particle size range of 125–250 µm, and AC2—micronized AC1 with a mean particle size of ~1 µm. We measured haematological parameters white blood cells, red blood cells, platelet count, and haemoglobin level. Oxidative stress intensity was evaluated using the following markers: total levels of reactive oxygen species (ROS) in blood plasma; catalase activity (CAT) and pro-oxidant/antioxidant ratio in blood haemolysate samples; level of reduced glutathione (GSH) in liver tissues; oxidative modification of proteins, OPM (APHD, aldehyde–dinitrophenylhydrazone derivatives and KPHD, ketone dinitrophenylhydrazone derivatives) and malonic dialdehyde (MDA) in blood plasma and liver samples. Results: AC2 administration promoted significant myeloprotective effect: 1.5-fold increase in leukocytes, 2-fold in neutrophils, 1.5-fold in lymphocytes, and 1.23-fold in platelet count compared to the experimental Melphalan Group. At the same time, AC1 administration resulted in a slight increase in haematological parameters. Both ACs positively corrected important, but diverse, components of oxidative stress. They significantly reduced oxidative modification of blood and liver proteins (especially the AC1 form), normalized the level of reduced glutathione, pro-oxidant/antioxidant ratio and other markers. For some markers, such as ROS production in blood plasma, the use of enterosorbents resulted in non-significant a shift towards normal parameters. Conclusions: Oral activated carbon adsorbents reduce oxidative stress intensity and myelotoxicity; they can be promising means to combat the adverse effects of chemotherapy in clinical practice.

1 January 1992 in Clinical Materials
Verified
Journal Article
Closed access
VNV.G. Nikolaev
V.G. Nikolaev
VSV.V. Sarnatskaya
V.V. Sarnatskaya
EEE.V. Eretskaya
E.V. Eretskaya
ESElisaveta Snezhkova
Elisaveta Snezhkova
NBN.V. Belitser
N.V. Belitser